These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7071030)

  • 21. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 22. Dosing intervals in intralymphatic immunotherapy.
    Hjálmsdóttir Á; Wäckerle-Men Y; Duda A; Kündig TM; Johansen P
    Clin Exp Allergy; 2016 Mar; 46(3):504-7. PubMed ID: 26470052
    [No Abstract]   [Full Text] [Related]  

  • 23. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral routes for immunotherapy: clinical efficacy and kinetics of the allergen.
    Canonica GW; Passalacqua G; Mariani G; Motta C; Bartolomei M; Mistrello G; Falagiani P; Bagnasco M
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1997; (91):56-64; discussion 64-7. PubMed ID: 9383892
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapy concepts under investigation.
    Kündig TM
    Allergy; 2011 Jul; 66 Suppl 95():60-2. PubMed ID: 21668859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intralymphatic Immunotherapy: Update and Unmet Needs.
    Senti G; Freiburghaus AU; Larenas-Linnemann D; Hoffmann HJ; Patterson AM; Klimek L; Di Bona D; Pfaar O; Ahlbeck L; Akdis M; Weinfeld D; Contreras-Verduzco FA; Pedroza-Melendez A; Skaarup SH; Lee SM; Cardell LO; Schmid JM; Westin U; Dollner R; Kündig TM
    Int Arch Allergy Immunol; 2019; 178(2):141-149. PubMed ID: 30391954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyposensitization: indications and expectations].
    Urbanek R
    Padiatr Padol; 1990; 25(6):397-404. PubMed ID: 2080061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The mechanisms of allergen-specific immunotherapy more clear].
    Rak S
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
    [No Abstract]   [Full Text] [Related]  

  • 29. [Not Available].
    Harr T; Spertini F; Seebach J
    Rev Med Suisse; 2017 Apr; 13(557):731-732. PubMed ID: 28722360
    [No Abstract]   [Full Text] [Related]  

  • 30. [The value of immunotherapy in treatment of IgE-induced allergic diseases].
    Müller UR
    Ther Umsch; 1994 Jan; 51(1):67-76. PubMed ID: 7511841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of polymerized allergens for immunotherapy.
    Grammer LC; Patterson R
    Asian Pac J Allergy Immunol; 1983 Jun; 1(1):55-8. PubMed ID: 6681109
    [No Abstract]   [Full Text] [Related]  

  • 34. Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment?
    Epstein TE; Tankersley MS
    J Allergy Clin Immunol Pract; 2017; 5(5):1227-1233. PubMed ID: 28709818
    [No Abstract]   [Full Text] [Related]  

  • 35. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 36. Modulation of immune responses by immunotherapy in allergic diseases.
    Cavkaytar O; Akdis CA; Akdis M
    Curr Opin Pharmacol; 2014 Aug; 17():30-7. PubMed ID: 25062122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of allergy and allergen specific immunotherapy.
    Bidad K; Nicknam MH; Farid R
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):1-9. PubMed ID: 21358009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A review of allergoid immunotherapy: is cat allergy a suitable target?
    Nguyen NT; Raskopf E; Shah-Hosseini K; Zadoyan G; Mösges R
    Immunotherapy; 2016; 8(3):331-49. PubMed ID: 26860435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen immunotherapy, routes of administration and cytokine networks: an update.
    Cuppari C; Leonardi S; Manti S; Filippelli M; Alterio T; Spicuzza L; Rigoli L; Arrigo T; Lougaris V; Salpietro C
    Immunotherapy; 2014; 6(6):775-86. PubMed ID: 25186606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergen-specific immunotherapy: current concepts and future directions.
    Bieber T; Simon HU
    Allergy; 2011 Jun; 66(6):709-12. PubMed ID: 21518373
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.